The Role of Topically Dissolved Oxygen (TDO) to Ameliorate Signs of Photodamage

Completed · Phase 2 · Has a placebo group

Conditions studied: Rosacea, Acne Vulgaris, Atopic Dermatitis, Seborrheic Dermatitis

In brief

This study is an evaluation of the role of topical dissolved oxygen to lessen visible signs of photodamage using a select regimen of topical dissolved oxygen containing cosmeceutical products. Evaluation of the overall skin tolerability of topical dissolved oxygen (safety) utilizing the regimen of products.

Key facts

Study ID
NCT00991198
Run by
Aria Aesthetics Inc.
People needed
49
Starts
2009-09-01
Expected to finish
2010-01-01
Last updated by the study team
2011-06-08

Who can join

Age: 25 and older, up to 60. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.